Mu Su

机构：Harbin Medical University, Taipei Medical University Hospital, Zhejiang Cancer Hospital, Third Affiliated Hospital of Harbin Medical University, Shenzhen Institutes of Advanced Technology, Zhejiang Fashion Institute of Technology, Stanford University · ORCID：0000-0002-3923-1303

发表论文 81 篇 · 总被引 1442 次 · h-index 16

代表论文

EphA2 super-enhancer promotes tumor progression by recruiting FOSL2 and TCF7L2 to activate the target gene EphA2 (2021 · Cell Death and Disease · 被引 40)
Prediction of Transcription Factors Binding Events Based on Epigenetic Modifications in Different Human Cells (2020 · Epigenomics · 被引 30)
An analysis about heterogeneity among cancers based on the DNA methylation patterns (2019 · BMC Cancer · 被引 23)
Accurate Prediction of Prognosis by Integrating Clinical and Molecular Characteristics in Colon Cancer (2021 · Frontiers in Cell and Developmental Biology · 被引 13)
On the growth and form of bacterial colonies (2025 · Nature Reviews Physics · 被引 12)
The signature of pharmaceutical sensitivity based on ctDNA mutation in eleven cancers (2020 · Experimental Biology and Medicine · 被引 12)